Speech-Language Pathologists in Independence, OH Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Molly Schenker, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5000 Rockside Rd, Independence, OH 44131 Phone: 216-901-2300

Ruth Jerome, MACCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5000 Rockside Rd Ste 500, Independence, OH 44131 Phone: 216-459-2846    Fax: 216-901-2803

Mrs. Rita Marie Liguzinski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5000 Rockside Rd Ste 500, Independence, OH 44131 Phone: 216-459-2846    Fax: 216-901-2803

Kelsey Christine Blatt, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6046 Brecksville Rd, Independence, OH 44131 Phone: 216-232-4900

Ms. Bethany Ann Koch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4511 Rockside Rd, #330 Supplemental Health Care, Independence, OH 44131 Phone: 216-901-0400    Fax: 216-901-0401

Barbara Holland Bobal, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6046 Brecksville Rd, Independence, OH 44131 Phone: 216-232-4900

News Archive

Scientists find interaction between amyloid and tau proteins that cause brain damage linked with AD

For years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheimer's disease (AD). Which one is the driving force behind dementia? The answer: both of them, according to a new study by researchers at the Douglas Mental Health University Institute.

Scientists uncover how microbiota metabolise complex dietary carbohydrates found in fruits, vegetables

We are all aware of the health benefits of "dietary fibre". But what is dietary fibre and how do we metabolise it?

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.

Ultrasound can predict high risk of stroke in patients with asymptomatic carotid stenosis

A new study shows that a simple ultrasound test may help to identify people at high risk of stroke who have a condition called asymptomatic carotid stenosis, a narrowing of the carotid artery found in the neck, in which few or no symptoms are present.

Read more Medical News

› Verified 6 days ago